GLP, or Good Laboratory Practice, refers to a quality system of management controls for research laboratories and organizations to ensure the uniformity, consistency, reliability, reproducibility, quality, and integrity of chemical and pharmaceutical non-clinical safety tests. It encompasses organizational processes and conditions under which laboratory studies are planned, performed, monitored, recorded, archived, and reported.
GLP standards were developed to promote the quality and validity of test data used for determining the safety of chemicals and chemical products. These practices are required by law in many countries for non-clinical animal studies that support or are intended to support applications for research or marketing permits for products regulated by government agencies.
GLP is crucial in clinical research as it ensures the quality and integrity of non-clinical safety data used to support human clinical trials. By following GLP standards, researchers can provide regulators with reliable information to assess the safety of new drugs or medical devices before they are tested in humans.
Adherence to GLP principles also enhances the reproducibility of study results and facilitates international acceptance of data. This standardization helps streamline the drug development process, potentially reducing the time and cost associated with bringing new treatments to market while maintaining high safety standards.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2025 Axcellant